A Biotechnological Method Provides Access to Aggregation Competent Monomeric Alzheimer's 1–42 Residue Amyloid Peptide
- 1 September 1995
- journal article
- research article
- Published by Springer Nature in Nature Biotechnology
- Vol. 13 (9) , 988-993
- https://doi.org/10.1038/nbt0995-988
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- Amyloid β Protein (Aβ) in Alzheimeri's Disease BrainJournal of Biological Chemistry, 1995
- Relative abundance of Alzheimer A beta amyloid peptide variants in Alzheimer disease and normal aging.Proceedings of the National Academy of Sciences, 1994
- Visualization of Aβ42(43) and Aβ40 in senile plaques with end-specific Aβ monoclonals: Evidence that an initially deposited species is Aβ42(43)Neuron, 1994
- An Increased Percentage of Long Amyloid β Protein Secreted by Familial Amyloid β Protein Precursor (βApp 717 ) MutantsScience, 1994
- beta-Amyloid-(1-42) is a major component of cerebrovascular amyloid deposits: implications for the pathology of Alzheimer disease.Proceedings of the National Academy of Sciences, 1993
- The carboxy terminus of the .beta. amyloid protein is critical for the seeding of amyloid formation: Implications for the pathogenesis of Alzheimer's diseaseBiochemistry, 1993
- β-amyloid peptide in vitro toxicity: Lot-to-lot variabilityNeurobiology of Aging, 1992
- Assembly and aggregation properties of synthetic Alzheimer's A4/beta amyloid peptide analogs.Journal of Biological Chemistry, 1992
- The molecular pathology of Alzheimer's diseaseNeuron, 1991
- New metal chelate adsorbent selective for proteins and peptides containing neighbouring histidine residuesJournal of Chromatography A, 1987